Portfolio Manager/Sub-Investment Adviser
TBCAM's Global Research Team07/31/2013
TBCAM is a subsidiary of BNY Mellon with its principal office at BNY Mellon Center, One Boston Place, Boston, Massachusetts 02108. TBCAM was founded in 1970 and manages more than $43.654 billion in assets in international and domestic equity and balanced portfolios for public, corporate, Taft-Hartley, defined benefit plans, as well as endowment/foundation clients and sub-advised relationships. TBCAM, subject to Dreyfus' supervision and approval, provides investment advisory assistance and research and the day-to-day management of the fund's investments. A discussion regarding the basis for the board's approving the sub-investment advisory agreement between Dreyfus and TBCAM will be available in the fund's annual report for the period ended October 31, 2013.
Investment decisions for the fund are made by members of TBCAM's global research team. The team members primarily responsible for managing the fund are Elizabeth Slover and Matthew D. Griffin, CFA, positions they have held since the fund's inception. Ms. Slover is a senior managing director at TBCAM, and is the director of TBCAM's global research team. She has been employed by TBCAM since 2005. Mr. Griffin is a managing director and portfolio manager at TBCAM, and is a member of TBCAM's global research team. He has been employed by TBCAM since 2006.
Top Holdings 2
|Amc Networks, Cl. A||1.26%|
|Under Armour Cl.A||1.10%|
|Lin Media, Cl. A||1.09%|
|Las Vegas Sands Corp||1.06%|
|Number of Holdings||113
as of 03/31/14
|P/E Ratio 3||20.08
as of 02/28/14
Investors should consider the investment objectives, risks, charges, and expenses of the fund carefully before investing. Download a prospectus, or a summary prospectus, if available, that contains this and other information about the fund, and read it carefully before investing.
Notes & Disclosures
- Portfolio composition and allocation is as of 03/31/14 and is subject to change at any time. Totals may not be exact due to rounding. Negative exposures may represent short positions through derivatives.
- The holdings listed should not be considered recommendations to buy or sell a security. Large concentrations can increase share price volatility.
- Price/earnings for a stock is the ratio of the company's most recent month-end share price to the company's estimated earnings per share (EPS) for the current fiscal year. If a third-party estimate for the current year EPS is not available, Morningstar will calculate an internal estimate based on the most recently reported EPS and average historical earnings growth rates. Price/ earnings is one of the five value factors used to calculate the Morningstar Style Box. For portfolios, this historical P/E data point is calculated by taking an asset-weighted average of the earnings yields (E/P) of all the stocks in the portfolio and then taking the reciprocal of the result. Source: Morningstar